12/22/2022:
Deventer, on Wednesday 21 December 2022, GD Group signed the acquisition agreement for Agrobiogen GmbH, Xenogenetik Ges.mbH, Nexttec GmbH and Nexttec Inc. Agrobiogen and Xenogenetik specialise in molecular genetic research and veterinary diagnostics, and Nexttec produces innovative DNA extraction kits. The knowledge and expertise of these companies and their approximately 25 employees ties in well with the offerings of the other group companies and the ambition for further international growth. The companies are based in Germany, Austria and the United States.
Agrobiogen GmbH was founded in 1997 by veterinarian Prof. dr. Gottfried Brem. The company is DIN EN ISO/IEC 17025:2018 accredited by German accreditation body DAkkS and has become a customer-oriented, trusted and flexible partner for veterinarians and livestock farmers. The company specialises in molecular genetic research for individual farm animals, populations and other animals. In addition, diagnostics are performed for various infectious diseases in various animal species. Nexttec GmbH, which produces and markets innovative DNA extraction kits internationally and has a branch in the US, also becomes part of GD Group.
Founder of Agrobiogen veterinarian Prof. dr. Gottfried Brem on the acquisition: “Agrobiogen’s research results support breeding programmes, provide veterinarians and livestock farmers with valuable information on the health status and genetic characteristics of animals, help control animal diseases and ultimately contribute to ensuring food quality. In GD Group, we have found a partner with whom we can continue our mission and customer services both regionally and internationally. For Nexttec, the group offers new expansion opportunities.”
GD Group’s ambition is to be a valuable partner for animal health. Agrobiogen shares this ambition, is a fully accredited company and a customer-oriented, trusted and flexible partner for veterinarians and livestock farmers in the region. Kris Van Malderen, co-Managing Director of GD Group: “Agrobiogen’s activities tie in well with those of the Group. In addition, this acquisition marks the first step in veterinary diagnostics in southern Germany, a region with many cattle. It will be GD Group’s second branch in Germany – our subsidiary Van Haeringen already has a branch in North Rhine-Westphalia – and its first branches in Austria and the US.”
About GD Group
GD Group is the parent company of Royal GD, GD Labnet, Van Haeringen Group, Anymal, Het Woud and Litams. GD Group’s ambition is to be a valuable partner for animal health, both now and in the years to come. Besides farm animals, the Group’s companies also focus on backyard animals, companion animals and horses, and also examines human and plant samples.
GD Group is working towards a healthily expanding and efficient organisation. Besides growing our operations domestically, GD Group also sees opportunities for further international growth. Van Haeringen Group has subsidiaries in Germany, Belgium and Norway. GD Group achieved a consolidated turnover of 80 million in 2021 and has around 500 employees.